Influence of continuous intravenous pump with remazolam on anesthetic effect during perioperative period: a randomized controlled trial.

Influence of continuous intravenous pump with remazolam on anesthetic effect during perioperative period

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033534

Enrollment

Unknown

Registered

2020-06-04

Start date

2020-06-10

Completion date

Unknown

Last updated

2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia

Interventions

Group 1:Intravenous infusion

Group 2:Continuous intravenous pump

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-65 years; 2. ASA (American Society of Anesthesiologists physical status score) I-II patients; 3. Patients with BMI of 18-30 kg / m2.

Exclusion criteria

Exclusion criteria: 1. Patients who are known to be sensitive or contraindications to benzodiazepines; 2. Patients with glaucoma and myasthenia gravis; 3. Patients with shock, coma and acute alcoholism.

Design outcomes

Primary

Measure	Time frame
Bispectral Index (BIS);Observer's Assessment of Alertness/Sedation Scale;	—

Countries

China

Contacts

Public ContactZhang Junlong

Lianyungang Second People's Hospital Affiliated to Bengbu Medical College

zjlddqzyw@126.com+86 15715139688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026